Cargando…

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome

BACKGROUND: Irritable Bowel Syndrome (IBS) is a prevalent, chronic gastrointestinal disorder that imposes a substantial socioeconomic burden. Peppermint oil is a frequently used treatment for IBS, but evidence about cost‐effectiveness is lacking. OBJECTIVE: We aimed to assess cost‐effectiveness of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weerts, Zsa Zsa R. M., Essers, Brigitte A. B., Jonkers, Daisy M. A. E., Willems, Jeresa I. A., Janssen, Deborah J. P. A., Witteman, Ben J. M., Clemens, Cees H. M., Westendorp, Audrey, Masclee, Ad A. M., Keszthelyi, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Neurogastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598953/ https://www.ncbi.nlm.nih.gov/pubmed/34468079 http://dx.doi.org/10.1002/ueg2.12134

Ejemplares similares

The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome
por: Sturkenboom, Rosel, et al.
Publicado: (2021)

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2019)

Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2020)

Correction: Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational Study
por: Weerts, Zsa Zsa R M, et al.
Publicado: (2021)

Age-Related Decrease in Abdominal Pain and Associated Structural- and Functional Mechanisms: An Exploratory Study in Healthy Individuals and Irritable Bowel Syndrome Patients
por: Beckers, Abraham B., et al.
Publicado: (2021)

Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in the Human Colon
por: Baumard, Lucas, et al.
Publicado: (2021)

Examining the optimal cutoff values of HADS, PHQ‐9 and GAD‐7 as screening instruments for depression and anxiety in irritable bowel syndrome
por: Snijkers, Johanna T. W., et al.
Publicado: (2021)

Integrated fecal microbiome–metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome
por: Mujagic, Zlatan, et al.
Publicado: (2022)

Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study
por: Seeling, Katharina Sophie, et al.
Publicado: (2023)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
por: Melchior, Chloé, et al.
Publicado: (2022)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study
por: McEvoy, Mark A., et al.
Publicado: (2021)

Epithelial expression and function of trypsin-3 in irritable bowel syndrome
por: Rolland-Fourcade, Claire, et al.
Publicado: (2017)

Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome
por: Vasant, Dipesh H, et al.
Publicado: (2020)

Digital Instruments for Reporting of Gastrointestinal Symptoms in Clinical Trials: Comparison of End-of-Day Diaries Versus the Experience Sampling Method
por: Beckers, Abraham B, et al.
Publicado: (2021)

Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies
por: McPherson, Zachary E., et al.
Publicado: (2021)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
por: Garsed, Klara, et al.
Publicado: (2014)

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
por: Akbar, A, et al.
Publicado: (2008)

How to address work impairment in patients with disorders of the gut–brain interaction?
por: Keszthelyi, Daniel
Publicado: (2023)

Incidence and prevalence of eosinophilic oesophagitis: Are we reaching a plateau?
por: Masclee, Gwen M. C., et al.
Publicado: (2022)

Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome
por: van Assen, Tijmen, et al.
Publicado: (2012)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
por: Melchior, Chloé, et al.
Publicado: (2022)

Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2018)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
por: Tooth, David, et al.
Publicado: (2014)

Do Patients’ and Physicians’ Perspectives Differ on Preferences for Irritable Bowel Syndrome Treatment?
por: Sturkenboom, Rosel, et al.
Publicado: (2022)

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice
por: Noble, Hithin, et al.
Publicado: (2022)

Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
por: Everitt, Hazel Anne, et al.
Publicado: (2019)

Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing
por: Eccles, Jessica Anne, et al.
Publicado: (2020)

Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?
por: Vork, Lisa, et al.
Publicado: (2021)

The use of non‐invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance
por: Mommersteeg, Michiel C., et al.
Publicado: (2023)

Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders
por: Jones, Michael P., et al.
Publicado: (2021)

Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence
por: Goelen, Nick, et al.
Publicado: (2023)

Acute psychological stress increases paracellular permeability and modulates immune activity in rectal mucosa of healthy volunteers
por: Gerdin, Linda, et al.
Publicado: (2022)

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
por: Wauters, Lucas, et al.
Publicado: (2021)

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
por: Savarino, Edoardo, et al.
Publicado: (2022)

α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABA(B) receptors
por: Castro, Joel, et al.
Publicado: (2017)

European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations
por: Tornkvist, Navkiran T., et al.
Publicado: (2022)

Prior hospital‐based infection and risk of eosinophilic esophagitis in a Swedish nationwide case‐control study
por: Uchida, Amiko M., et al.
Publicado: (2022)

Gastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls
por: Sangnes, Dag A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_32l4sogc9t1nsoqc5fbni6less